Recently, it has also been shown that ferroptosis‐related genes such as GPX4 and SLC7A11, could serve as a novel biomarker for predicting the prognosis in breast cancer (another class of BRCA‐related cancer) patients.25 This evidence concerns the gene SLC7A11 and breast carcinoma.